Replimune Group, Inc. carries a market capitalization of 1.04B, placing it among publicly traded companies globally. Its enterprise value stands at 846.30M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.04B |
| Enterprise Value | 846.30M |
Replimune Group, Inc. currently has 83.98M shares outstanding.
| Shares Outstanding | 83.98M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | 8.80 |
| P/TBV Ratio | 8.80 |
| P/FCF Ratio | -3.74 |
| P/OCF Ratio | -3.72 |
Replimune Group, Inc. maintains a current ratio of 5.23, meaning it holds 5.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 105.99, indicating elevated leverage, while an interest coverage ratio of -29.43 demonstrates limited ability to service its debt obligations.
| Current Ratio | 5.23 |
| Quick Ratio | 5.09 |
| Debt / Equity | 105.99 |
| Debt / EBITDA | -0.38 |
| Interest Coverage | -29.43 |
| Return on Equity (ROE) | -134.29 |
| Return on Assets (ROA) | -82.28 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
| Income Tax | -551,000.00 |
| Effective Tax Rate | N/A |
Replimune Group, Inc.'s stock has gained approximately 23.46369% over the past 52 weeks. The 50-day moving average sits at 13.75, while the 200-day moving average is 9.05.
| Beta (5Y) | N/A |
| 52-Week Price Change | 23.46369% |
| 50-Day Moving Average | 13.75 |
| 200-Day Moving Average | 9.05 |
| Average Volume (20 Days) | N/A |
EBITDA reached -292.87M, while operating income came in at -296.26M.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -296.26M |
| Pretax Income | -297.56M |
| Net Income | -297.01M |
| EBITDA | -292.87M |
| EBIT | -296.26M |
| Earnings Per Share (EPS) | -3.17 |
Replimune Group, Inc. holds 195.33M in cash and equivalents against 111.98M in total debt, resulting in a net debt position of -101.24M. Total book value stands at 105.65M, with working capital of 162.40M providing operational flexibility.
| Cash & Cash Equivalents | 195.33M |
| Total Debt | 111.98M |
| Net Debt | -101.24M |
| Equity (Book Value) | 105.65M |
| Book Value Per Share | 1.26 |
| Working Capital | 162.40M |
Replimune Group, Inc. produced -279.06M in operating cash flow over the past twelve months. After subtracting -1.49M in capital expenditures, free cash flow totaled -280.54M - equivalent to -3.00 per share.
| Operating Cash Flow | -279.06M |
| Capital Expenditures | -1.49M |
| Free Cash Flow | -280.54M |
| FCF Per Share | -3.00 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -7.23 |
| FCF Yield | -26.77 |
Replimune Group, Inc. posts an Altman Z-Score of -6.69, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -6.69 |